Skip to main content
MDxHealth, QUT bluebox enter scientific deal on oral cancer test

A scientific agreement between MDxHealth and QUT bluebox, the Queensland University of Technology's commercialization arm, will evaluate and develop a liquid biopsy epigenetic assay for early oral cancer detection. Under the deal, the first licensing option for commercial diagnostic rights will go to MDxHealth; proceeds will be used for research and translational activities at the university and MDxHealth's urologic cancer diagnostics research and development pipeline.

Full Story: